Athira's Alzheimer's Drug Passes Futility Analysis; Data Targeted For 2024

 
• By Jessica Merrill
  
car veering
Athira thinks its Alzheimer's drugs is back on the development road • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D